I don't really see how much I need to add to a report about the need to know how to breathe properly. I can only suggest that it is critically important and serves as a central feature of the work I do with the folks I consult with on improving their physical, mental and emotional health. The other point I can make is that knowing how to breathe and using that knowledge last month likely saved my life as I dealt with being infected with the COVID-19 virus. I also credit 5 days of clarithromycin and megadoses of Vitamin C and D and lots of morning sunshine and the love and care of my wife Nancy. When it came to the contractions and constant pressure in my lungs and chest, I needed to work on deepening (diaphragmatic) and slowing my respiration to 6/minute, I was glad to know what had to be done. 

I regret this is behind the WSJ paywall so maybe someone with a subscription can share the full text. https://www.wsj.com/articles/the-healing-power-of-proper-breathing-11590098696?mod=e2fb

I've commented before about the use of ultraviolet light wavelengths as a way to kill viruses and bacteria on surfaces. I'm happy now that we can add skin surfaces to this list with the use of a smaller band of UVC frequencies that won't harm human tissue. This represents a major advanc in our ability to prevent spread of the COVID 19 and other viruses by exposing them to these light frequencies. Products that can clean air ducts and hospital rooms will soon be helping stop the spread of the pandemic virus without harming people, animals or the environment. 

Quietmind Foundation's clinical facility in Elkins Park uses UVC to clean all the electronic equipment and surfaces in our treatment space and waiting area overnight. We continue to use the standard methods of masks, hand washing and Clorox wipes for some surfaces including everyone's  shoes before they enter. This is a really great advance using noninvasive and environmentally friendly technology to serve a very serious heath and safety need.

I located this bulb on Amazon and it delivers the far-UVC range of frequencies and covers a 30x20' space which is perfect for my consulting area at work. I can run the unit between sessions and have a virus free environment that won't cause skin damage or harm electronics.

https://smile.amazon.com/DuuToo-Lamp%EF%BC%88Double-Available%EF%BC%89Covers-Disinfection-lamp%EF%BC%88Remote/dp/B0886FPSZS/ref=sr_1_3_sspa?dchild=1&keywords=far+uvc+lamp&qid=1590150378&sr=8-3-spons&psc=1&spLa=ZW5jcnlwdGVkUXVhbGlmaWVyPUExSkk3MExFVUU0VjlYJmVuY3J5cHRlZElkPUExMDIyMjc1UDQ4TENRT01GVkpIJmVuY3J5cHRlZEFkSWQ9QTAzMDE5MjlNRDNNUVRUT1RERjgmd2lkZ2V0TmFtZT1zcF9hdGYmYWN0aW9uPWNsaWNrUmVkaXJlY3QmZG9Ob3RMb2dDbGljaz10cnVl#customerReviews

Welch, D., Buonanno, M., Grilj, V. et al. Far-UVC light: A new tool to control the spread of airborne-mediated microbial diseases. Sci Rep 8, 2752 (2018). https://doi.org/10.1038/s41598-018-21058-w

This article brings a greater level of clarity to the argument for APA and DSMV to validate and integrate neuroimaging data into psychiatric diagnosis and treatment. Further, we advocate the use of Quantitative EEG (QEEG) assessment technology because it offers the best temporal and spatial resolution of current imaging techniques. Quietmind Fdn. has used QEEG in its clinical research and treatment programs for 10+ years to determine the training protocols needed for people to improve their cognitive and behavioral functioning.  

Download the article here:
https://www.frontiersin.org/articles/10.3389/fpsyt.2020.00276/full

​We are now working with the development team at Independence Lighting (ILED) in Berwyn, PA to promote the development of innovative noninvasive non-drug treatment options for physical and behavioral symptoms of COVID-19 pandemic Our prior focus has been on studying treatments that employ infrared light and brainwave biofeedback for neuropsychiatric, neurodegenerative and neurodevelopmental disorders. Our goal is to help Independence LED create a save, low-cost, reliable and easily deployed device that can help reduce the chances of developing symptoms and reducing severity in those already infected.

We are seeking support for the initial basic science research we have proposed that will clarify the mechanisms that underlie treatment effectiveness. With the evidence from these studies ILED will then produce a device that can be scaled and distributed worldwide. You can review the basic science proposal here. 

independenceled.com/covid-19-led-phototherapy/

PBM Treatment Potential for COVID-19
There is a growing body of evidence showing that pulsed 1068nm infrared stimulation could serve as the basis for a safe, low-cost, non-drug, easily-deployed, noninvasive and home-based treatment for COVID-19. Current research evidence includes photobiomodulation as: 

• Antiviral via furin inhibition preventing viral attachment (infection) Evidence: UVB upregulates furin, causing toxicity and NIR inhibits UVB and elevates lymphocyte iNOS
• Antiviral - Acute pro-inflammatory (non cellular and cellular) for innate immune system to combat virus. Skin cell evidence
• Anti-inflammatory to protect host cells long term. Skin cell evidence
• Maintaining mitochondrial health for host cells long term.  Multi-cell evidence  
  
  

Quietmind Foundation has 1068nm transcranial stimulation units available for short-term rental.
Please contact Dr. Marvin Berman 610-940-0488 for details. 

The recent white paper by Michael Hamblin, PhD and Lew Lim, Vielight Inc. CEO, discusses the potential value of near infrared light stimulation using continuous 810nm photobiomodulation (PBM) along with 633nm intranasal stimulation. There is compelling evidence in the scientific literature supporting the therapeutic value of light stimulation to promote tissue level healing and ongoing neuroprotection. Quietmind Foundation has been studying the clinical value of photobiomodulation using Vielight and other PBM devices over the past 15 years and we now strongly advocate its inclusion along with central and peripheral biofeedback training in the treatment of neurodegenerative, neuropsychiatric and neurodevelopmental disorders. The evidence presented in this paper lends support for using PBM as a treatment for COVID-19 and other localized and systemic infections. 

QMF has already developed a research protocol and is seeking support to conduct studies that will provide evidence for the efficacy of PBM as a noninvasive treatment to boost immune response to COVID-19. We have been given a challenge grant that will match tax deductible donations up to $12,000 toward our goal of $45,000.
 
We are providing the X-plus, when they become available, with a 10% discount and no cost technical and clinical support. Please contact Dr. Marvin Berman for details at 610-940-0488.

​vielight-x-plus-for-covid-study-v2.pdf

Continuing the theme of what can we do right now to prevent infection with CV19, I want to stress the importance of aerobic exercise which stimulates the production of a powerful antioxidant "extracellular superoxide dismutase" (EcSOD). Exercise that increases breathing rate, depth and elevates heart rate will produce EcSOD. This is a very direct way we all can act to prevent infection and to improve our rate of recovery. I can attest to this from my own personal experience with recovering from CV19 infection last month. I practiced breathing techniques to deepen my intake to lower lobes, slowed my rate to 6 breaths a minute and climbed stairs in my South Philly row home (of which there are many) to get my heart rate up during my quarantine period. I think this routine along with infrared light stimulation and megadosing VitC and D helped me recover without heart, lung or kidney damage. 

This review paper by Zhen Yan, PhD, of the University of Virginia School of Medicine underscores the potential value of exercise as a way to prevent and/or minimize the severity of COVID-19 infection.  Quietmind Fdn. is offering consultation and support for people seeking to noninvasively promote their resistance to COVID-19 infection. Call Dr. Berman at 610-940-0488 for further information. 

www.eurekalert.org/pub_releases/2020-04/uovh-cem041520.php?fbclid=IwAR2Yu8o_rFqXZl3vbgJLpzkJVS63MshM-Pr5oG9TcxctxmkesXXat3UeFQM

FOR IMMEDIATE RELEASE
Berwyn, PA, March 16, 2020 – Independence LED Lighting (https://independenceled.com/) announces today its collaboration with the QuietMIND Foundation (https://www.quietmindfdn.org/), a public non-profit applied research foundation and integrative healthcare consulting practice to fast track development of low-cost, self-administered and easily deployed infrared (IR) phototherapy devices to enhance the immune system's ability to improve treatment outcomes and prevent the spread of COVID-19.

The current proposed solutions are rooted in decades of phototherapy research demonstrating how infrared (IR) light wavelengths can be safely and easily delivered. Current studies now show this type of therapy can slow the influenza virus and thereby diminish symptom severity and improve cerebral blood flow and oxygenation (Pruitt, 2020).  The “COVID-19 LED Phototherapy” is intended to boost immune system functioning for those who've already contracted COVID-19 while also developing methods to prevent the spread of infection. The effort is focused on fast-tracking basic science and applied clinical trials of devices that are safe, non-invasive and easily deployed for home-use. Such efforts would be running parallel to ongoing acute care and vaccine trials. The COVID-19 LED Phototherapy does not in any way reduce the need for the American public to practice currently recommended social distancing and isolation when necessary during this pandemic.  COVID-19 LED Phototherapy differs from other available low level PBM devices, in that, the wavelength and other delivery parameters for this development are likely to focus on wavelengths above 800nm.  The development team will collaborate closely with manufacturers and PBM researchers to optimize rapid scalable production and broad therapeutic impact.

COVID-19 LED Phototherapy – Patient treatment
Therapy can be administered via one or more of the following:

• Nasal insert devices
• Full body horizontal “beds” similar to tanning beds
• Full body “walk-in” chambers like those now used in gyms and spas.

 
COVID-19 LED Clinical Phototherapy – Research and Development
The R&D effort will address optimization of phototherapy delivery in terms of: 
1. Wavelength(s)
2. Power
3. Irradiance
4. Pulse rate/width
5. Dose response
6. Energy 
7. Fluence
8. Form factors for optimal treatment delivery, sustainability, and mass production/distribution.
 
In addition, we are strongly advocating using ultraviolet (UVC) LED light for sterilization as means to control viral contamination for surface cleaning at all treatment locations, as well as homes and businesses. People can safely return to work with this type of decontamination in place.  The QMF development team will work to define the most cost-effective hand-held and pass through whole body systems.
 
COVID-19 LED Phototherapy – Intellectual Property
The development team has agreed to open-source the COVID-19 LED Phototherapy technology and partner with local and global LED manufacturers and relevant supply chain partners during the pandemic to reduce the increase of infections and limit casualties and long-term disability due to compromised pulmonary, cardiovascular and neurological functions. Independence LED Lighting’s CEO, is also the 2020 Chairman of the Leadership Council of the American LED Alliance (https://americanledalliance.com/), which will help serve as a catalyst to provide product specifications and increase the roll-out of these phototherapy technologies.
 
COVID-19 LED Phototherapy – Fast-track Funding
This initiative requires global, multi-site R&D and testing over the next weeks and through the month of April to help slow the infections and casualties of the pandemic.  The development team is actively seeking $250,000, and the roll-out will then require added funding, which is expected to include joint public-private partnerships with organizations such as Centers for Disease Control and Prevention (CDC), National Health Service and WHO. Note: Funding support from a private foundation in New Jersey has already pledged $12,000, thank you! 
 
"This is an all hands on deck effort. Since 2010, when we moved our LED manufacturing from Shenzhen, China to southeastern Pennsylvania we have focused on a range of LED applications including installations for Walter Reed National Military Medical Center, US Navy hospital ships, the Department of Veterans Affairs (VA) Durham Medical Center, and private sector accounts like Thomas Jefferson University Hospital. We have also pioneered custom wavelength LEDs for advanced Photosynthetic Photon Flux Density (PPFD) for plant science. Now, we can apply our skills and focus to saving lives and positively affecting the growing economic crisis during this Coronavirus pandemic,” said Charlie Szoradi, CEO Independence LED Lighting,  “We are now facing an unprecedented health challenge.

Our focus has been on integrating light therapy and neuroscience to identify specific properties of light and noninvasive methods to improve central nervous system activity that will enhance immune system functioning. We're forging strategic relationships with local companies and academic research institutions in Philadelphia, United Kingdom, and Canada to expedite R&D and fast track roll-out of safe, reliable, low-cost, self-administered therapies.” said Marvin Berman, President, QuietMIND Foundation.
Contacts:
Charlie Szoradi, CEO, Independence LED Lighting
Direct: 610-551-5224, Charlie@IndependenceLED.com
Marvin Berman, President, QuietMIND Foundation
Direct: 610-940-0488, info@Quietmindfdn.org
​